Publicador de continguts

Recerca

OBERON

An integrative strategy of testing systems for identification of EDs related to metabolic disorders

Projecte OBERON
Durada
01/01/2019 - 31/12/2023
Coordinador
Karine Audouze
Finançadors
European Union’s Horizon 2020

Exposure to chemical substances that can produce endocrine disrupting effects represents one of the most critical public health threats nowadays. In line with the regulatory framework implemented within the European Union to reduce the levels of endocrine disruptors (EDs) for consumers, new and effective methods for ED testing are needed.

The OBERON project will build an integrated approach for testing and assessment (IATA) to detect endocrine disruptors-related metabolic disorders by developing, improving and validating a battery of test systems.

Total funding

€ 5,978,762

Our Team

Coordinator

  • Karine Audouze
    Karine Audouze

ISGlobal Team